| Table 1: Experimental group characteristics. |
| | Subject | Gender | Stroke Type | Stroke onset () | Age at assessment () | Affected hemisphere | Lesion area |
| | 1 | F | I | | | B | L: C R: S | | 2 | F | I | | | L | S | | 3 | M | H | | | R | S | | 4 | M | H | | | L | C/S | | 5 | M | H | | | B | L: C R: CB | | 6 | M | I | | | B | L: C/S R: S | | 7 | F | I | | | R | C/S | | 8* | F | I | | | B | L: C R: C | | 9 | M | I | | | L | C/S | | 10* | F | I | | | B | L: S R: S | | 11 | M | I | | | L | S | | 12 | M | H | | | L | BS | | 13 | M | H | | | R | S | | 14* | M | I/H | | | L | BS | | 15 | M | H | | | R | S | | 16 | M | H | | | R | C | | 17 | M | I | | | R | C | | 18* | F | I | | | B | R: C/S L: C | | 19 | F | I | | | R | C/S | | 20* | F | H/I | | | R | C/CB | | 21* | F | H | | | B | R:C/S L: S | | 22 | F | I | | | B | L: C/S R: S | | 23 | F | H | | | B | R: C/CB L: C/S | | 24 | F | I | | | L | C | | 25 | M | I | | | R | C/S | | 26 | F | H | | | R | C/S | | 27* | M | I | | | B | C/S | | 28 | M | I | | | L | C/S | | 29 | M | I | | | R | S |
|
|
*: recurrent stroke; F: female; M: male; H: haemorrhagic, I: ischemic; y: years, m: months; B: bilateral; R: right; L: left; C: cortical, S: subcortical; CB: cerebellum; TC: brainstem.
|